Eckert & Ziegler BEBIG: Change in management. Dirk Warmuth succeeds Edgar Löffler.
(Thomson Reuters ONE) -
Eckert & Ziegler BEBIG
Limited Liability Company whose securities are admitted to trading on a
regulated market
Registered office: Parc Industriel de Seneffe 1, 7180 Seneffe, Belgium
Company number: 0457.288.682 (RLE Charleroi)
Press release
REGULATED INFORMATION
23 December 2016, 18:15 pm
Seneffe/Berlin, December 23, 2016 - The Board of Directors of Eckert & Ziegler
BEBIG S.A. has appointed Dirk Warmuth (42) as Managing Director of Eckert &
Ziegler BEBIG GmbH with effect from January 1, 2017. He will succeed Dr. Edgar
Löffler (63), who will be stepping down as planned on December 31, 2016. Under a
long-term consulting agreement, he will continue to support the company.
"Since 2001, Dr. Löffler has played an instrumental role in the development of
our Therapy segment and in establishing Eckert & Ziegler as a major, globally
active provider of cancer radiation systems," Board of Directors Chairman Dr.
Andreas Eckert said. "Our success as the European market leader in prostate
implants would have been inconceivable without him. The Board of Directors and
the management would like to thank Edgar Löffler for these achievements and look
forward to continuing to have him at their side."
Dirk Warmuth will be responsible for production, development, and quality. He
has worked for the Eckert & Ziegler Group since 2008, most recently as Head of
Operations and as a member of the Radiopharma segment's management team. "In Mr.
Warmuth, we are gaining an acknowledged expert in his field, and we look forward
to working with him," Dr. Harald Hasselmann, Managing Director of Eckert &
Ziegler BEBIG GmbH and a member of the Eckert & Ziegler BEBIG S.A. Board of
Directors, explained.
About Eckert & Ziegler BEBIG
Eckert & Ziegler BEBIG is a European-based group active in the medical device
segment of the health care industry. Its core business is the treatment of
cancer using brachytherapy, a special form of radiation therapy. Eckert &
Ziegler BEBIG is a leader in brachytherapy in Europe. The company headquarters
are in Belgium, with a production facility in Germany and subsidiaries
throughout Europe, in the USA, India and Brazil. In addition, Eckert & Ziegler
BEBIG has a worldwide network of distributors and agents to support the
international marketing of its product line. The company's products and
equipment are intended for use by oncologists, radiologists, urologists and
medical physicists. Eckert & Ziegler BEBIG group employs approximately 130
people. The company has been listed on the Euronext stock exchange since April
1997.
Your contact :
Eckert & Ziegler BEBIG S.A.
Investor Relations
ir(at)bebig.com
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Eckert & Ziegler BEBIG via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 23.12.2016 - 18:15 Uhr
Sprache: Deutsch
News-ID 514743
Anzahl Zeichen: 3385
contact information:
Town:
Seneffe
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 375 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Eckert & Ziegler BEBIG: Change in management. Dirk Warmuth succeeds Edgar Löffler."
steht unter der journalistisch-redaktionellen Verantwortung von
Eckert & Ziegler BEBIG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
